Normally, NAB2 is a transcriptional repressor, while upon fusion, its repressor domain is truncated by STAT6, a transcriptional transactivator, resulting in a chimeric transcription factor located in the nucleus that drives the oncogenesis of SFT [43]. Here, STAT6 is linked to solitary fibrous tumor.